K193407: Contour® next GEN Blood Glucose Monitoring System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K193407 (Contour® next GEN Blood Glucose Monitoring System, cleared 2021-12-23 for Ascensia Diabetes Care) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K193407
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK193407
Cleared Device Trade / Generic NameContour® next GEN Blood Glucose Monitoring System
FDA Applicant on FilingAscensia Diabetes Care
FDA 3-Letter Product ClassificationProduct Code NBW
FDA Substantial Equivalence Decision Date2021-12-23
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at Ascensia Diabetes Care, compare peer devices under FDA Product Code NBW, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.